The Asthma Spacers Market Size is valued at 1.56 Billion in 2022 and is predicted to reach 2.69 Billion by the year 2031 at a 6.5 % CAGR during the forecast period for 2023-2031.
Spacers are a plastic tubes specifically designed to act as an interface between the pressurized metered-dose inhalers and patients. Spacers are also known as valved holding chanmber (VHC). The Spacers attaches to a pressurized metered-dose inhaler at one end and to the other end has mouthpiece to breathe through. The use of a spacer decreases the risk of drug underdose, minimizes oropharyngeal deposition and improves the amount of medication reaching to lungs. Spacers make pressurized metered dose inhalers (pMDI) comfortable to use by decreasing or eliminating the requirement for proper coordination between actuation and inhalation. The spacer helps proper delivery of drug by reducing the cold Freon effect. However, the benefits of spacers are offered at the cost of making pMDI system significantly large and less convenient. In general, spacers are categorized into Reverse-flow devices, Holding chambers, and Simple tube extensions to the actuator mouthpiece.
Market Segmentation
The asthma spacers market is segment based on brand, application, and geography. In terms of product the global market is segregated into Space Chamber Plus, A2A Spacer, Flo-Tone CR, Able Spacer, AeroChamber, Volumatic, Vortex, OptiChamber. High R&D activities and rising adoption rate for Spacer are the major factor that drives the growth of the market. The market players are highly active in delivering value products complying the customer need. The companies in the asthma spacers market invest considerably in research and development activities to develop highly advanced products. Increasing awareness about the new technology through multi-channel marketing and activities has led to an increase in demand for the new products.
Based on application, the market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies. Based on geography, the global asthma spacers market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, Europe followed by North America is the major contributor for the global asthma spacers market. According to WHO report 2018, approximately 334 million are suffering from asthma. Various government initiatives and activities carried global organisations has raised healthcare accessibility deeper in the worldwide market.
Rising awareness about asthma treatment, growing market access to the drugs, increase in purchasing power of an individual are the key components fostering the asthma spacers market to propel substantially. Increasing research and development activities performed by industry players, has been fostering innovations in the product offerings. Due advancements in the product offerings have resulted in an increase in market demand for asthma spacers for respiratory treatment.
Competitive Landscape
Some Of The Key Players In The Asthma Spacers Market:
- Medical Development International,
- Trudell Medical International,
- Pari GmbH,
- Conmed Corporation,
- GlaxoSmithKline,
- Merck & Co., Inc,
- Koninklijke Philips N.V,
- AstraZeneca,
- Cipla,
- Clement Clarke,
- Lupin,
- Fisons,
- Bird Healthcare,
- InspiRX Inc
The Asthma Spacers Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 1.56 Billion |
|
Revenue Forecast In 2031 |
USD 2.69 Billion |
|
Growth Rate CAGR |
CAGR of 6.5 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Brand, By Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Medical Development International, Trudell Medical International, Pari GmbH, Conmed Corporation, GlaxoSmithKline, Merck & Co., Inc, Koninklijke Philips N.V, AstraZeneca, Cipla, Clement Clarke, Lupin, Fisons, Bird Healthcare, InspiRX Inc. and many more. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
